Avalon BioVentures

Managing Partner at Avalon BioVentures with over 30 years in investing, operations, and scientific research. He led investments in Aratana, Synthorx, Janux, and Nerio and has driven over 30 investments across Avalon funds. He holds a PhD from the University of Illinois with postdoctoral work at Yale and Dupont Merck.

Managing Partner and serial entrepreneur with 30 years of experience in corporate financing, operations, and M&A. He co-founded Enlaza Therapeutics and was co-founder/CEO of Nerio Therapeutics, and earlier led Calporta and other Avalon portfolio companies. He earned his PhD in Genetics from SUNY Stony Brook.

Managing Partner and drug discovery scientist with over 20 years in biotechnology. He co-founded and serves as CEO of Enlaza Therapeutics and previously co-founded Nerio and Calporta. He holds a PhD in organic chemistry from the University of Illinois at Urbana-Champaign.

CPA and Managing Partner serving as CFO of the Accelerator and its portfolio companies, with over 25 years in senior finance and taxation. He was acting CFO of Janux and Synthorx and CFO of Nerio. He holds an M.S. in Taxation and B.S. in Accounting from San Diego State University.

Financial Planning & Analysis Manager who joined the Accelerator in 2014, supporting financial strategy across portfolio companies. She holds an MBA from Cornell and a B.S. in Biology from UC Santa Barbara.

Executive Assistant to the Partnership and senior portfolio executives who joined in 2023, with extensive experience as a legal and executive assistant in Southern California.

Advisor since 2024 supporting portfolio companies with business development, strategy, and operations, with over 10 years in the biopharmaceutical industry. He holds an MBA from Duke and an M.Sc. in Biomedical Nanotechnology from Northeastern.

Head of Human Resources who joined in 2012, leading HR strategy across portfolio companies. She holds a BBA from the University of San Diego and an HR Management certification from UCSD.

Advisor since 2020 with over 20 years in small-molecule drug discovery, currently CSO of Cohesyx Bio and SVP of Biology at Protalys. He earned his PhD in Biology from UC San Diego.

Senior Accounting Manager who joined in 2019 overseeing accounting operations, with prior roles at Becton Dickinson, Novartis, and AstraZeneca. He earned a B.S. in Accounting from Cal State San Marcos.

Advisor since 2015 with over 15 years in medicinal chemistry and drug discovery, currently CSO at Protalys and VP of Chemistry at Cohesyx Bio. He earned his PhD in Chemistry from UC Irvine.

Advisor since 2025 with 20 years in synthetic biology and cell and gene therapy, currently CSO of Tregsherpa and CDO of Korsa Therapeutics. She earned her PhD in Immunology from UT Southwestern.

VP of Finance who joined in 2021, a California CPA with over a decade of experience in biotech accounting. She holds a B.S. in Management Science from UC San Diego.

Accounts Payable Manager who joined in 2015, managing financial transactions and vendor relationships, with prior accounting roles at Cadence Pharmaceuticals, Sony Ericsson, and Intuit. She earned a B.S. from San Diego State University.

Lab and Facilities Manager who joined in 2024, overseeing operations, procurement, EHS, and lab management with a background in the biotech industry.

Administrative Assistant who joined in January 2024, providing operational support across portfolio companies. She holds a B.S. in Business Administration from San Diego State University.

Fund Controller who joined in 2015 overseeing fund accounting and financial reporting, previously with roles at DJO. He holds a B.S. from USC and is a California CPA.